Orlando, FL -- (SBWIRE) -- 10/07/2013 -- Hot Stock Profits provides investors and traders with valuable trading tools and content as well as micro-cap stock alerts via eMail and text messages. To Join Our Text Message Alerts Service Just Text The Word Stocks To 555888 From Your Cell Phone. Our Focus Today Is On Pfizer Inc.(NYSE:PFE), Johnson & Johnson (NYSE:JNJ).
Pfizer Inc.(NYSE:PFE) shares gained 0.80% to $29. The company on Oct. 3 announce that the United States Food and Drug Administration (FDA) has approved DUAVEETM (conjugated estrogens/bazedoxifene) 0.45mg / 20mg tablets, a novel therapy for women with a uterus, for the treatment of moderate-to-severe vasomotor symptoms associated with menopause and the prevention of postmenopausal osteoporosis.
Additionally, the company on Sept. 24 announced that 20 abstracts for XELJANZ® (tofacitinib citrate), the first in a new class for the treatment of rheumatoid arthritis (RA), oral Janus kinase (JAK) inhibitors, will be presented at the American College of Rheumatology (ACR) / Association of Rheumatology Health Professionals (ARHP) 2013 Annual Meeting, which is being held October 25-30 in San Diego, CA. XELJANZ is approved in the United States for the treatment of adults with moderately to severely active RA who have had an inadequate response or intolerance to methotrexate, at a dose of 5 mg tablet twice daily.
Are investors worried about the recent updates with PFE? Find out with a free trend analysis HERE
Johnson & Johnson (NYSE:JNJ) shares increased 0.84% to $87.31. The company on Oct. 1 said it is on watch following reports that it might have received bids for its diagnostics unit. Reuters said that private equity firms like Blackstone Group LP (NYSE: BX), KKR & Co. (NYSE: KKR), Bain Capital LLC, Carlyle Group (Nasdaq: CG), and BC Partners Ltd. are among firms that have submitted first-round bids for J&J's Ortho Clinical Diagnostics unit. Market watchers suspect that the unit could ultimately draw $5 billion or more.
Is JNJ going to continue its rally or drop like a rock? Find out with a free trend analysis HERE
Join Our Mobile SMS Alerts By Texting Stocks To 555888
HotStockProfits.com continuously monitors and scans the markets for day trading and swing trading signals on NASDAQ, NYSE, AMEX, OTCBB and Pink Sheet companies for its free e-newsletter subscribers.
HotStockProfits.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit HotStockProfits.com website, for complete risks and disclosures.
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)